HIF1A and acute myeloid leukemia: In the present study, we conducted a series of in vitro assays, aimed to explore the molecular mechanism of miR-19a-3p/HIF-1α in simvastatin inhibiting AML, to lay a theoretical foundation for possible clinical application in the future.